We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Cardio-Pulmonary Device Minimizes Dependence on Mechanical Ventilation during Cardiac Surgery

By HospiMedica International staff writers
Posted on 18 Sep 2023
Print article
Image: Inspira has announced 510(k) FDA submission of INSPIRA ART100 towards commercialization (Photo courtesy of Inspira)
Image: Inspira has announced 510(k) FDA submission of INSPIRA ART100 towards commercialization (Photo courtesy of Inspira)

Every year, millions of patients in need of external breathing assistance require ventilation and oxygenation via external mechanical ventilation machinery. These traditional ventilation systems often lead to a range of problems such as physical injury, infections, and even death. Now, a revolutionary cardio-pulmonary bypass device reduces reliance on mechanical ventilation during cardiac surgery by delivering next-generation superior treatment.

The INSPIRA ART100 from Inspira Technologies (Ra'anana, Israel) is an extracorporeal blood circulation device designed to provide cardiac and pulmonary support. With the ability to oxygenate and circulate blood for up to six hours during cardiac surgery, it is expected to be the first system designed for integration with the company’s non-invasive HYLA blood sensor technology. The HYLA device allows for continuous, real-time blood monitoring, which could reduce the need for taking blood samples from patients and help doctors keep an eye on their clinical condition.

The INSPIRA ART100 features a user-friendly large touchscreen and an intuitive graphical interface that provides a clear and comprehensive display of data for medical teams. The device has a compact and lightweight design, as it is built using aerospace-grade aluminum, making it both durable and easy to move. It also comes with a long-lasting battery, adding to its suitability for patient use throughout a hospital setting. Inspira Technologies has submitted the device for approval to the U.S. Food and Drug Administration through the 510(k) pathway, with a potential green light expected in the first half of 2024.

"We are preparing for global deployments of our INSPIRA ART100 systems once FDA clearance is achieved,” said Dagi Ben-Noon, CEO of Inspira. “Our future systems can save millions of lives and change external respiratory aid for over 20 million people each year. We aim to be a part of this market over the next 5 years and are moving aggressively to achieve these goals."

Related Links:
Inspira Technologies

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Surgical Camera
AIM 4K

Print article

Channels

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.